is to serve greater longevity and prevent heart disorders for elevated heart risk groups through innovative and clinically proven predictive algorithms
The ultimate vision we have is to be an essential part of the population’s health monitoring and heart disease prevention systems, providing the best prognostic tools for managing heart health and leading the prediction of cardiovascular diseases (CVD), chronic fatigue and burnout.
We act on values of Health Sustainability, Innovation, Reliability and Collaboration to globally improve people's heart health.
Chief Executive Office
Has MS in Computer & Data Science and is an impeccable project manager with more than 25 years of experience in leading multinational complex projects, such as European Commission initiative for the 15 Nuclear Power Plants maintenance optimisation and the Global Tuberculosis Fund projects management. She is a natural leader, truly passionate about improving heart health, and a serial entrepreneur who bootstrapped the company with her life savings.Read more
Chief Science Officer
MD, multiple PhD with more than 25 years of practicing in cardiology. He's the globally-renowned scientist, whose invaluable experience gained at Institute of Cybernetics, the Ukrainian Academy of Science, his German Radgein University PhD work and multiple researches form the core of Cardiolyse CE-certified ECG processing algorithms and patents. Illya is leading an advisory PhDs in Cardiology, Cybernetics, Neural Networks and Data Science, that together with the development team are constanly improving and clinically validating our algorithms.Read more
First algorithms finalized and web-platform developed
Oxford University and China Kadoorie Biobank ongoing validation project start
Patents for Method of ECG Evaluation Based on Universal ECG Scoring System filed
Ongoing pilot on CVD remote heart health monitoring in India start
Fatigue Risk Management proof of concept for liability insurance launched
Company brand update, Heart Health monitoring Android and iOS app update
Stay tuned for our news
We've successfully risen €500К for Cardiolyse initial platform developmen, market research and clinical trials, along with first successful pilots with world's key players from insurance and pharma sectors, hospital inpatient and outpatient units.Read more
Cardiolyse has opened its last investment round now to grow exponentially, conduct cardiovascular researches of global value, maintain further clinical trials and develop more product features of patients' and healthcare providers' value while enhancing our team with the robust talent to tackle emerging challenges and receiving certifications for the next markets enter.
Find out more about Cardiolyse investment opportunities
to join the healthcare digital transformation movement and leave your lasting footprint in cardio diagnostics advancement
Send us a word regarding any question or suggestion you have
Let’s work together
on heart health improvement